Overall, The SETD2 positive rate in tumor cells was lower than that in normal epithelial cells (15.2 vs. 20.2%, p = 0.2, Figure 5C), but higher than that in immune cells, including T/NK cells (10.7%, p < 0.0001), B cells (8.4%, p < 0.0001), and myeloid cells (12.1%, p < 0.0001). The gene discussed is SETD2; the disease is neoplasm.